|
Volumn 91, Issue 6, 2001, Pages 840-845
|
Effects of docetaxel in combination with radiation on human head and neck cancer cells (ZMK-1) and cervical squamous cell carcinoma cells (CASKI)
|
Author keywords
Docetaxel; Radiosensitisation; Radiotherapy; SCC cell lines
|
Indexed keywords
DOCETAXEL;
PACLITAXEL;
RADIOSENSITIZING AGENT;
ARTICLE;
CELL CYCLE G2 PHASE;
CELL SURVIVAL;
CLONOGENIC ASSAY;
CONTROLLED STUDY;
CYTOTOXICITY;
DOSE TIME EFFECT RELATION;
FLOW CYTOMETRY;
HEAD AND NECK CANCER;
HUMAN;
HUMAN CELL;
IRRADIATION;
PRIORITY JOURNAL;
RADIOSENSITIZATION;
SQUAMOUS CELL CARCINOMA;
UTERINE CERVIX CARCINOMA;
CARCINOMA, SQUAMOUS CELL;
CELL CYCLE;
CELL SURVIVAL;
COMBINED MODALITY THERAPY;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
FLOW CYTOMETRY;
HEAD AND NECK NEOPLASMS;
HUMANS;
PACLITAXEL;
RADIATION TOLERANCE;
RADIATION-SENSITIZING AGENTS;
RADIOTHERAPY;
TAXOIDS;
TIME FACTORS;
TUMOR CELLS, CULTURED;
UTERINE CERVICAL NEOPLASMS;
|
EID: 0035869657
PISSN: 00207136
EISSN: None
Source Type: Journal
DOI: 10.1002/1097-0215(200002)9999:9999<::AID-IJC1142>3.0.CO;2-U Document Type: Article |
Times cited : (34)
|
References (26)
|